Playtika Holding Corp. financial statements

Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Playtika Holding Corp. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,491	1,888	2,372	2,583	2,616	2,567	2,549	2,755
Cost of revenue	437	566	712	729	736	719	692	759
Gross profit	1,054	1,321	1,659	1,854	1,880	1,849	1,857	1,997
Research and development	148	211	269	387	472	406	403	427
Selling and marketing	293	414	502	582	604	586	705	950
General and administrative	180	200	501	323	332	304	289	619
Operating income	433	497	387	562	471	502	392	-5.1
Interest expense	0.5	61.6	198	149	118	154	155	143
Pre-tax income	112	91.9	-48.5	408	361	392	281	-173
Income tax	92.7	147	102	99.9	85.5	157	118	33.5
Income from continuing operations	338	289	92.1	309	275
Net income	338	289	92.1	309	275	235	162	-206
EBITDA	450	521	425	605	517	547	438	41.7
EPS, basic	0.89	0.76	0.24	0.75	0.69	0.64	0.44	-0.55
EPS, diluted	0.89	0.76	0.24	0.75	0.69	0.64	0.44	-0.55
Shares, basic (weighted)	378	378	385	409	401	366	372	376
Shares, diluted (weighted)	378	378	385	411	402	367	372	376
Dividend per share							0.40	0.40

Balance sheet

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	306	267	520	1,017	769	1,030	566	684
Short-term investments				100	0	0	0	136
Other current assets		4.7	11.6	12.6	10.1	7.9	5.2	14
Total current assets		477	755	1,336	1,025	1,351	873	1,064
Property, plant and equipment		82.8	98.5	103	126	120	115	103
Lease right-of-use assets		58	73.4		104	100	89.9	124
Goodwill	221	474	485	788	811	987	1,692	1,696
Intangible assets		357	328	417	354	311	562	426
Other non-current assets		3.3	7.3	13.4	157	152	167	116
Total assets		1,480	1,776	2,803	2,698	3,175	3,639	3,719
Accounts payable		352	485	495	385	438	463
Accrued liabilities		100	122	95.6	110	93.9	113	142
Deferred revenue			21.3	31.6	38.6	46	36.4	28.8
Short-term debt		138	105	12.2	12.4	16.8	11.6	11.1
Total current liabilities		554	640	570	462	540	559	968
Long-term debt		2,320	2,210	2,423	2,411	2,400	2,389	2,378
Lease liabilities		52.4	67	82.3	94.5	88.2	71.4	115
Other non-current liabilities				23.7	252	319	372	381
Total liabilities		3,096	3,020	3,181	3,266	3,397	3,770	4,130
Total debt		2,320	2,210	2,423	2,424	2,416	2,400	2,389
Paid-in capital		202	462	1,033	1,156	1,265	1,363	1,423
Retained earnings		-1,819	-1,726	-1,418	-1,143	-908	-894	-1,251
Treasury stock				0	-604	-604	-604	-604
Other comprehensive income		-2.9	16.7	3.2	17.6	20.6	-0.2	15.9
Shareholders' equity	465	-1,616	-1,244	-378	-569	-222	-131	-411
Total equity	465	-1,616	16.7	-378	-569	-222	-131	-411
Total liabilities and equity		1,480	1,776	2,803	2,698	3,175	3,639	3,719
Shares outstanding		378	391	411	364	370	375	377

Cash flow statement

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	338	289	92.1	309	275	235	162	-206
Depreciation and amortization	17.5	23.6	37.6	42.5	45.9	45.7	46.5	46.8
Stock-based compensation	0	0	276	100	124	110	99.2	82.5
Deferred income tax	-5.2	40.8	-13.1	-72.4	-48.7	-56.9	-34.7	-54.3
Change in receivables	4.9	-15.4	-1.7	-7.5	1	-25.6	10.1	28.6
Change in payables	4.6	8	-20.2	5.9	5.7	-9.3	-21.3	24.2
Cash from operations	453	492	518	552	494	516	490	568
Capital expenditures	-41.1	-55.3	-54.1	-47.4	-68.3	-32.6	-40.9	-36.3
Acquisitions	-3	-423	0	-394	-29.9	-160	-687	0
Purchases of investments			0	-100	0	0	-257	-336
Cash from investing	142	-517	-98.1	-609	-74.6	-240	-782	-222
Debt repaid		-2,673	0	-965	-19	-14.3	-23.8	-19
Stock issued		0	-2.4	470	0	0
Dividends paid	-400	-2,366	0	0	0	0	-112	-150
Cash from financing	-337	-6.6	-181	560	-652	-18.2	-167	-230
Exchange rate effect	-2.5	-2.4	13.3	-6.6		4.1	-4.9	2
Net change in cash	-29	-33.6	252	495	-249	261	-464	118
Free cash flow	412	437	464	504	425	483	449	531
Interest paid						146	147	137
Income taxes paid	86.5	62.8	81.1	102	161	170	92.6	103

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $2.13 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	73.5%	Gross profit / revenue.
Operating margin	-3.4%	Operating income / revenue.
EBITDA margin	-1.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-9.3%	Pre-tax income / revenue.
Net margin	-9.9%	Net income / revenue.
FCF margin	14.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	16.1%	Cash from operations / revenue.
Return on assets (ROA)	-8.5%	Net income / average total assets.
Return on invested capital (ROIC)	-5.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	14.2%	Research and development expense / revenue.
Stock-based pay / revenue	2.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.2%	Capital expenditures / revenue.
D&A / revenue	1.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	8.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	7.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	2.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	3.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-101.3%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-90.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-56.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-37.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-227.3%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-225.0%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	15.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	4.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	1.9%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	18.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	7.7%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	2.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	2.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	11.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	15.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.14x	Current assets / current liabilities.
Quick ratio	0.70x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.70x	(Cash + short-term investments) / current liabilities.
Debt / assets	72.4%	Total debt / total assets.
Liabilities / assets	112.1%	Total liabilities / total assets.
Net debt	$1.95B	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$85.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	62.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$2.47B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.86x	Revenue / average total assets.
Fixed asset turnover	29.8x	Revenue / average property, plant and equipment.
Capex / operating cash flow	7.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.73	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$7.40	Revenue / diluted weighted shares.
FCF per share	$1.10	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.19	Cash from operations / diluted weighted shares.
Book value per share	-$1.05	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$6.48	Tangible book value / shares outstanding.
Cash per share	$1.15	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	27.0%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$812.4M	Share price x shares outstanding.
Enterprise value	$2.76B	Market cap + total debt - cash - short-term investments.
P/S	0.29x	Market cap / revenue.
P/FCF	1.94x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	1.79x	Market cap / cash from operations, when positive.
EV/Sales	0.97x	Enterprise value / revenue.
EV/FCF	6.58x	Enterprise value / free cash flow, when both are positive.
FCF yield	51.6%	Free cash flow / market cap.
Earnings yield	-34.4%	Net income / market cap (the inverse of P/E).
Dividend yield	13.9%	Dividends paid over the period / market cap.
Shareholder yield	13.9%	(Dividends paid + share buybacks) / market cap.

What was Playtika Holding Corp.'s revenue in fiscal 2025?

Playtika Holding Corp. reported revenue of $2.76B for fiscal 2025, 8.1% higher than the year before.

Was Playtika Holding Corp. profitable in fiscal 2025?

No. It reported a net loss of $206.4M.

How much free cash flow did Playtika Holding Corp. generate in fiscal 2025?

Cash from operations of $567.7M minus capital expenditures of $36.3M left free cash flow of $531.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Playtika Holding Corp.